SOURCE: Revolutions Medical Corporation

Revolutions Medical Corporation Logo

October 06, 2014 09:18 ET

Revolutions Medical Receives COFEPRIS Registration to Import RevVac™ Safety Syringes Into Mexico

MOUNT PLEASANT, SC--(Marketwired - October 06, 2014) - Revolutions Medical Corporation (PINKSHEETS: RMCP) received notification from the Comision Federal Para La Proteccion Contra Riesgos Sanitarios (COFEPRIS) (Federal Commission for Protection against Health Risks) that the RevVac™ safety syringes have been registered and approved. This registration permits all sizes of the RevVac™ auto retractable vacuum safety syringes to be imported into Mexico. The Company has endeavored for the past two years to diligently work through the lengthy process to receive this registration. The health care market in Mexico is one of the largest in the world and the Company is optimistic that the benefits of the RevVac™ safety syringe brings will be well received in Mexico.

The Company would like to recognize its exclusive RevVac™ safety syringe distributor in Mexico, Comercializadora Nura, S.A. de C.V. and its President Oscar Salazar, for all the help in achieving this registration. Based in Mexico City, Mexico, Comercializadora Nura has been providing cutting edge products to the Mexican market for almost 18 years.

"We believe with the reception the RevVac™ safety syringe has received in the Mexican health care market so far, this unique safety syringe will reduce costs, reduce accidental needle stick injuries, and reduce the spread of infectious diseases and we aim to share these benefits throughout Mexico," states Oscar Salazar, President of Comercializadora Nura.

About Revolutions Medical Corporation

Revolutions Medical Corporation is a safety medical device company. Its proprietary products and technologies include: the RevVac™ safety syringe, safety blood drawing device and prefilled vacuum auto-retraction safety syringes.

For additional information, please visit Revolutions Medical corporate website:

To be added to the Revolutions Medical investor email list, please email: with RMCP in the subject line.


The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information

    Revolutions Medical Corporation
    Tel.: (843) 971-4848
    Investor Relations